PRODUCT

Arthrinox Capsules

Arthrinox Dietary Supplement Product
  • Diabenox Dietary Supplement Product
  • 60 Capsules (Net weight 36g)
  • Centella asiatica juice powder
  • Black sesame extract
  • Isolated soy protein
  • Guava fruit juice powder
  • Mangosteen aril juice powder

 

 

Ingredients:
  • One capsule (600 mg.) contains
  • Centella asiatica juice powder 150 mg. (25%)
  • Black sesame extract 100 mg. (16.67%)
  • Isolated soy protein 100 mg. (16.67%)
  • Guava fruit juice powder (refined) 100mg. (16.67%)
  • Mangosteen aril juice powder 50 mg. (8.32%)

 

 

Direction

1 - 3 capsules , 2 - 3 times a day 1 hour before meals or bedtime.

 

 

 

The following results are based on Clinical studies conducted at the Biomedical Technology Research Centre at Chiang Mai Faculty of Medical Technology, Chiang Mai University in 2011.

 

In this study, the dosage was to test the efficacy and safety of prescribing a maximum of 4 capsules per day. (2 capsules each before meals)

 

Results ::Arthrinox Capsules - 4 per day / 15 days

 

12 subjects (6 usedArthrinoxCapsules and 6 used Placebo)

 

 

Effects of Arthrinox Capsules

 

  • Significantly lowers TNF-α
  • Lowers IL6
  • Lowers IL17
  •  

 

The significant decrease in TNF-α reduces the severity of Inflammation and Auto Immune symptoms. Autoimmune diseases are characterized by the body's immune responses being directed against its own tissues, causing prolonged inflammation and subsequent tissue destruction. Auto immune disorders can either cause immune-responsive cells to attack the linings of the joints (resulting in rheumatoid arthritis).

 

In rheumatoid arthritis, excess levels of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin 1(b) (IL-1b), and/or leukotriene B4 (LTB4), are known to cause or contribute to the inflammatory syndrome that ultimately destroys joint cartilage and synovial fluid.

 

IL 17 Role in Asthma

 

The IL-17F gene been shown to have a pro-inflammatory role in asthma. IL-17F is clearly expressed in the airway of asthmatics and its expression level is correlated with disease severity. Over expression of IL-17F gene in the airway of mice is associated with airway neutrophilia, the induction of many cytokines, an increase in airway hyper reactivity, and mucus hyper secretion. Hence, IL-17F may have a crucial role in allergic airway inflammation, and have important therapeutic implications in asthma. http://en.wikipedia.org/wiki/Interleukin_17

 

 

Other conditions:

 

  • Rheumatoid / Osteo-Arthritis
  • SLE
  • Skin rash
  • Hyperthyroid
  • Parkinson’s symptom
  • Asthma
  • Gout
  • Liver Malfunction etc.
  •